Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 4/2006

01.04.2006 | Image of the month

The possible role of 68Ga-DOTATATE PET in malignant abdominal paraganglioma

verfasst von: Zarni Win, Lucy Rahman, Joy Murrell, Jeannie Todd, Adil Al-Nahhas

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 4/2006

Einloggen, um Zugang zu erhalten

Excerpt

Paragangliomas are rare tumours that arise within the sympathetic nervous system originating from the neural crest. Nearly 90% of these tumours originate in the medulla of the adrenal glands, and are known as phaeochromocytomas. The remaining 10% are extra-adrenal and are termed paragangliomas. In all, 10% are malignant, and these are often difficult to manage. …
Literatur
1.
Zurück zum Zitat Ell PJ, Gambhir SS. Nuclear medicine in clinical diagnoses and treatment. 3rd ed. New York: Churchill Livingstone; 2004 Ell PJ, Gambhir SS. Nuclear medicine in clinical diagnoses and treatment. 3rd ed. New York: Churchill Livingstone; 2004
2.
Zurück zum Zitat Hofmann M, Maecke H, Borner R, Weckesser E, Schoffski P, Oei L, et al. Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data. Eur J Nucl Med 2001;28:1751–7PubMedCrossRef Hofmann M, Maecke H, Borner R, Weckesser E, Schoffski P, Oei L, et al. Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data. Eur J Nucl Med 2001;28:1751–7PubMedCrossRef
3.
Zurück zum Zitat Kowalski J, Henze M, Schuhmacher J, Macke HR, Hofmann M, Haberkorn U. Evaluation of positron emission tomography imaging using [68Ga]-DOTA-DPhe1-Tyr3-octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol 2003;5:42–8PubMedCrossRef Kowalski J, Henze M, Schuhmacher J, Macke HR, Hofmann M, Haberkorn U. Evaluation of positron emission tomography imaging using [68Ga]-DOTA-DPhe1-Tyr3-octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol 2003;5:42–8PubMedCrossRef
4.
Zurück zum Zitat Lewington V. Targeted radionuclide therapy for neuroendocrine tumours. Endocr Relat Cancer 2003;10(4):497–501PubMedCrossRef Lewington V. Targeted radionuclide therapy for neuroendocrine tumours. Endocr Relat Cancer 2003;10(4):497–501PubMedCrossRef
Metadaten
Titel
The possible role of 68Ga-DOTATATE PET in malignant abdominal paraganglioma
verfasst von
Zarni Win
Lucy Rahman
Joy Murrell
Jeannie Todd
Adil Al-Nahhas
Publikationsdatum
01.04.2006
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 4/2006
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-005-0035-9

Weitere Artikel der Ausgabe 4/2006

European Journal of Nuclear Medicine and Molecular Imaging 4/2006 Zur Ausgabe